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1. Introduction 
Early-life exposure to adverse experience or stress, simply termed early-life stress (ELS), is a 
worldwide problem that has a significantly negative impact in human health [1, 2]. In the 
United States, about 50% of adults had experienced some kind of stress before age 18 [3], 
and up to 15-25% of adults had traumatic ELS such as sexual abuse [4]. Most ELS is parents-
originated, such as neglect, maltreatment, and abuse [5, 6]. In addition to the immediate, 
dreadful, and destructive effects on a child’s life, ELS may produce a series of mental [7, 8], 
cardiovascular [9, 10], metabolic [11, 12], and many other types of disease [13, 14], at a later 
life stage. For example, adults who were sexually abused during childhood have a 5.7-fold 
increase in risk for drug abuse over those without ELS [7], and the prevalence of 
posttraumatic stress disorder (PTSD), a predominant form of anxiety disorders (ADs), is 
highly associated with ELS, with a 4-5 fold difference between adults with ELS and those 
without ELS [15]. Moreover, cognitive dysfunctions [16-18] such as learning and memory 
impairment [19-21] are also highly associated with ELS. Given that children, especially early 
adolescents, have a higher possibility to expose to a traumatic insult [22], adolescent trauma 
(AT) is an important risk factor for these post-ELS disorders.  
Over the past decades, considerable insights have been gained into the molecular/neuronal 
mechanisms regarding how ELS impacts brain function and behavior [23-26]. Generally, it is 
now accepted that ELS can produce changes, most permanently, at multiple levels [25, 27]. 
Following ELS, for example, the overall volume of the hippocampus [28-30], corpus 
callosum [31-33], and cortex [34-36] all becomes smaller, compared to that of those brain 
regions in age-matched subjects. Besides these neuroanatomical changes, the neuronal 
activity and the synaptic function in the brain in ELS-victims are impaired [37-39], and most 
neurotransmitter systems are significantly affected too. By using positron emission 
tomography or fMRI, it has been found that a significantly increased release of dopamine in 
the ventral striatum is associated to ELS [40, 41]. The turnover rate of the serotonin (5-HT) 
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metabolism or the 5-HT receptor density [42, 43] is altered following ELS. Similarly, the 
activity of the glutamatergic system [44, 45] and the cholinergic system [46, 47] are also altered 
in the brain of individuals following ELS. However, it should be emphasized that the changes 
in the hypothalamic-pituitary-adrenal (HPA) axis activity is of the most interest [48-52]. 
As the most important stress-related neuroendocrine system in the body, the HPA axis is 
anatomically and functionally composed of three major structures: the paraventricular 
nucleus of the hypothalamus (PVN), the anterior lobe of the pituitary gland, and the adrenal 
gland [53, 54]. The PVN contains magnocellular neurosecretory neurons that synthesize and 
release a corticotropin-releasing factor (CRF). CRF is a 41 amino acid peptide [55, 56], and can 
bind to three types of G-protein-coupled receptors: CRFR1, CRFR2, and CRFR3 [57-59]. In the 
mammalian brain, both CRF and CRFR1 are mainly distributed in the limbic system, while 
CRFR-2 is in the hypothalamus [60-62]. The essential role for the CRF system is to maintain the 
basal HPA axis activity as well as to trigger the HPA axis in response to stresses. After released 
from the PVN, the CRF binds to CRFR1 at the anterior pituitary and increase the release of 
adrenocorticotropic hormone (ACTH). The ACTH consequently stimulates the release of 
glucocorticoids from the adrenal gland [63]. Once released, glucocorticoids bind both high-
affinity mineralocorticoid receptors and lower-affinity glucocorticoid receptors. The 
glucocorticoids, or cortisol in humans and corticosterone in rodents, play an essential role in 
energy metabolism, growth processes, immune function, and brain functions [63, 64].  
In response to stress, CRF system plays an essential role in modifying peripheral 
physiological response to support “fight or flight” reactions, such as mobilizing energy 
stores, increasing blood sugar and heart rate, inhibiting digestive functions etc [65,66]. In 
addition, CRF itself may act on CRFR2 in the brain to directly regulate adaptive behavioral 
changes encountering stress [67-69]. Taken together, the CRF/HPA system plays a primary 
role in coordinating the endocrine, autonomic, immune, and behavioral response to stress. 
As stress, either real or imaged, is a necessary inducer for ADs, the CRF/HPA system must 
play a unique role in anxiety-related behaviors. Indeed, a huge body of evidence has 
documented this notion. For example, administration of CRF [70-72] or CRFR1 agonists 
[69,73,74] or overexpression of the CRF gene [75-77] produces Anxiety-like behaviors (ALBs) 
in the animals. On the other hand, CRFR1 antagonists exert significantly anxiolytic effects 
[78-80]. Knockout of CRF or CRFR1 in mice significantly reduces ALBs to stress and 
dramatically blunts stress-induced HPA axis activity [61,81,82]. Remarkably, previous 
chronic stress is able to enhance HPA axis activity in response to a novel acute stress, 
despite the negative feedback effects of increased glucocorticoids produced by the chronic 
stress [83-85]. For example, CCK-4-induced panic status in healthy volunteers significantly 
increases HPA axis activities [86]. Even the effects of early-life stress on HPA axis function 
are found to be associated with CCK sensitivity 130. Most interestingly, interactions between 
the CCKergic system and the CRF/HPA system exist [88-90]. For example, the CCKergic 
system was found to be involved in this chronic stress-enhanced responsiveness, since 
chronic stress can specifically facilitate the release of CCK into the PVN, which directly 
projects to the pituitary, in response to acute stress 125. All these findings have not only 
established the role of the CRF/HPA system in initiating behavioral responses to stresses, 
 
CCKergic System, Hypothalamus-Pituitary-Adrenal (HPA) Axis, and Early-Life Stress (ELS) 23 
but also indicate that a significant interaction may exist between the CRF/HPA system and 
CCKergic system to regulate stress-related behaviors. 
However, the vulnerability among different individuals to AT is different. This variability 
may at least partially attribute to a genetic variability [91]. A twin study of Vietnam veterans 
revealed that about 37.9% of vulnerability to PTSD was genetically related [92]. Further 
genetic evidence comes from clinical association studies, by which several candidate genes 
for ADs including PTSD have been associated, although a causative gene has not been yet 
established [91]. Among those candidate genes, cholecystokinin (CCK) receptor-2 (CCKR-2) 
has been linked to panic disorder, another major form of ADs [93,94]. 
As the most abundant neuropeptides, CCK distributes broadly in the brain and mainly in 
the limbic system [95,96]. CCK binds to CCK receptor-1 (CCKR-1) and CCKR-2, of which the 
CCKR-2 is predominantly found in the brain with the highest level in cortical area and the 
limbic system [97], a brain region that is critically involved in emotion response and 
behavior. Virtually, the CCKergic system has long been recognized as an anxiogenic factor 
for the animals [98], and this effect has been well validated in human populations as well 
[89,99,100]. Our recent study also showed that overexpression of CCKR2 in neurons of the 
forebrain of mice significantly enhanced ALBs [101]. At the same time, some candidate 
genes that are linked to ADs are also associated with HPA axis activity. For example, a 
common polymorphism at the serotonin transporter (5-HTT) gene, namely 5HTTLPR, is a 
strong candidate genetic variation for ADs and depression [102-103], and also is 
significantly implicated in HPA axis activity [104]. Similar to the CCKergic system, the HPA 
axis system has long been recognized as a stress hormone [105,106], and plays a critical role 
in the pathogenesis of ADs [107,108]. Indeed, following ELS, the activity of the HPA axis 
system is dysfunctional [109-111]. Moreover, given the overall role of both the HPA axis 
system [112-114] and the CCKergic system [115-117] in regulating neuronal, cardiovascular, 
and metabolic functions in the body, these two systems may play an integrative role in the 
pathogenesis of post-ELS disorders. 
In this study, by using our previously engineered inducible forebrain-specific CCKR-2 
transgenic (IF-CCKR-2 tg) mice [101], we demonstrated that the elevated CCKergic tone in 
the brain significantly facilitated the effect of AT on the impairment of the glucocorticoid 
negative feedback inhibition in response to a novel acute stressor during the adult stage in 
the mouse, providing direct evidence that reveals a molecular basis for this co-effect.  
2. Materials and methods 
2.1. Experimental animals  
The procedures for the generation of IF-CCKR-2 tg (simply dtg) mice were described in our 
previous publication [101]. Briefly, we used the tTA/tetO-inducible gene expression system to 
produce these dtg mice. This system requires two independent transgenic mouse strains, tTA 
transgenic and tetO/CCKR-2 transgenic mice. Accordingly, two constructs were made. The 
first was for tTA transgenic mice, in which the expression of the tTA was under the control of 
an alpha-Ca2+ calmodulin kinase II (CaMKII) promoter. The tTA transgene cassette consists of 
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0.6 kb of exon-intron splicing signal (pNN265), 1.0 kb of tTA encoding sequence (pTet-Off, 
Clontech), and 0.5 kb of SV-40 poly-A signals (pTet-Off, CLONTECH). The other construct is 
for CCKR-2 transgenic mice, in which the expression of the CCKR-2 transgene was under the 
control of the tetO promoter. The CCKR-2 transgene cassette consisted of 1.3 kb of mouse 
CCKR-2 cDNA, an upstream 0.6 kb of splicing signal (pNN265), and a downstream 1.1 kb of 
b-globin poly-A signals. All these components were subcloned into the pTRE2 vector 
(CLONTECH). CCKR-2 cDNA was cloned by RT-PCR from the total RNA extracted from the 
brain of a male B6/CBA F1 mouse (The Jackson Laboratory) with the primers of 5'-CGG GAT 
CCA TGG ATC TGC TCA AGC TG-3' and 5'-GCT CTA GAT CAG CCA GGT CCC AGC GT-
3'. A commercial RNA extraction kit (Invitrogen) and a reverse transcription kit (Stratagene) 
were used. The cloned cDNA was confirmed by sequencing. The plasmid constructs were then 
linearized with suitable enzymes and separately injected into the pronucleoli of B6/CBA F1 
zygotes, as described [118]. Transgenic founders and the transgene copy numbers were 
determined by Southern blot analyses of the tail DNA. Founder mice with suitable gene copy 
numbers were backcrossed into B6/CBA F1 mice first to produce hemizygous single transgenic 
mice and then to produce double hemizygous transgenic mice. We have totally generated nine 
CaMKII-tTA transgenic founders and seven tetO-CCKR-2 transgenic founders. Southern blot 
analyses indicated that the gene copy numbers were from 2 to 70 for tTA transgenic founders 
and 2-150 for CCKR-2 transgenic founders (data not shown). To map the tTA expression 
pattern in the brain, we crossed a tetO-Lac-Z reporter mouse line (SJL-TgN-tetoplacZ, the 
Jackson Laboratory) into different independent CaMKII-tTA mouse lines to produce different 
tTA-LacZ double transgenic mouse lines. For Lac-Z staining, a commercial X-Gal staining kit 
(Invitrogen) and the recommended staining protocol were used with sagittal brain sections (30 
µm), by which we identified a tTA transgenic line that was of the capacity to drive tetO/gene 
expression in almost all the neurons in the forebrain region (data not shown). Genotyping was 
determined by PCR analyses of both tTA (5'-AGG CTT GAG ATC TGG CCA TAC-3' and 5'-
AGG AAA AGT GAG TAT GGT G-3') and the CCKR-2 (5'-ACG GTG GGA GGC CTA TAT 
AA-3' and 5'-GAG TGT GAA GGG CATG CAA-3') transgenes. Dtg mice used here were 
around 12-16 generations since they were generated, during which duration dtg mice were 
backcrossed into B6/CBA F1 mice in every 5-6 generations, in order to avoid an inbreed effect. 
Single transgenic (tTA or tetO-CCKR-2 only) and wild-type (wt) littermates of dtg mice were 
used as controls, and are collectively and simply called wt mice hereafter.  Mice used here 
were kept in standard laboratory mouse cages under the standard condition (12 hours 
light/dark cycle, temperature at 22 ± 1 oC, humility at 75%) with food and water ad libitum. All 
experimental procedures for the use of animals were previously reviewed and approved by 
the institutional animal care and use committee at the Louisiana State University Heath 
Sciences Center at New Orleans, and all of the experiments were conducted in accordance 
with the Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health. 
2.2. In situ hybridization  
The hybridization was used to detect the expression level and pattern of the CCKR-2 
transgene in the brain. Brains from both wt and dtg mice were collected by decapitation, 
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and were frozen with powered dry ice immediately. Sagittal sections (20 µm) were made 
with a Cryostat (Leica, CM 1900, Richmond, IL). An oligo probe for tTA and a cRNA probe 
for the total CCKR-2 mRNAs were labeled with 35S UTP (>1,000 Ci/mmol; NEN, Boston, 
MA) by a random labeling kit and in vitro transcription kit (Invitrogen, Carlsbad, CA), 
respectively. The hybridization was performed overnight at 55°C, and after washing, slides 
were exposed to Kodak BioMax film (NEN) for the same time.  
2.3. Adolescent trauma (AT)  
Both wt and dtg mice at the age of P25 were individually put into a small shock-box (4 X 4 X 
10 inch in high) that was modified from the shock box from a fear-conditioning system 
(Coulbourn Instruments, Whitehall, PA), in order to ensure that the mice did not have much 
space for escaping during shocking. The current of the footshock was higher (1.0 mA) than it 
was commonly used in the fear-conditioning test (0.6-0.8 mA). The footshock was conducted 
for 5 times (trials), in total, during a period of 1 minute, and each trial lasted for 2 seconds, 
with an interval of 10 seconds between trials. 
2.4. Acute stressor (AS)  
Additional acute stressor (AS; 0.8 mA for 2 seconds for one trial) with a standard fear-
conditioning paradigm as described previously [119], was used to trigger HPA axis reaction 
at the age of P60 (2 months).   
2.5. ELISA  
Commercially available kits for both the adrenocorticotropic hormone (ACTH) (MD 
Bioproducts, St. Paul, MN) and corticosteroid hormone (CORT) (R&D systems, Minneapolis, 
MN) were used to determine the serum level of these hormones. Experimental procedures 
followed the recommended steps. In order to have samples enough for triplicate 
measurements, blood was collected with a retroorbital eye bleeding method. In order to 
minimize non-specific effects, blood collection was conducted at 9:00 Am, and the procedure 
was completed within 30 seconds, by which time any possible change that might be 
produced by the sampling procedure was not yet measurable. 
2.6. Statistical analysis  
Both female and male mice were almost equally distributed in each group. Data were 
analyzed with one-way ANOVA, followed by post-hoc tests.  The p value less than 0.05 is 
considered significant.  
3. Results 
3.1. Expression of the CCKR-2 transgene in the brain of dtg mice 
As shown in Fig 1, in situ hybridization revealed that the expression of the tTA was 
forebrain-specific in dtg mice (Fig. 1B), but was not detectable in wt mice (Fig. 1A). The 
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expression pattern of the CCKR-2 transgene (data not shown) was the same as both the 
pattern of the tTA expression and the CCKR-2 transgene expression reported in our 
previous study [101].  
 
Figure 1. Expression pattern of the tTA mRNA detected by in situ hybridization with saggital brain 
sections in wt (A) and dtg (B) mice.  
3.2. Dtg mice with AT exhibit an increased HPA axis activity in response to AS 
Either wt (n = 60) or dtg mice (n = 60) were subjected to AT, and then were divided into 5 
groups (n = 12) for a time-course study, in which both ACTH and CORT were examined 
before the AS for the basal level, and 1, 2, 4, and 8 hours following the AS. As shown in Fig. 
2, although the difference in the basal level of ACTH (Fig.  2A) or CORT (Fig. 2C) between 
these mice was not significant, a tendency of a lower level ACTH (p = 0.0741) and CORT (p = 
0.0648) was observed in dtg groups, compared to wt groups. Following the AS, an one-way 
ANOVA revealed a significant effect of the AT and CCKR-2 transgene on ACTH [F(1,8) = 
6.781, p < 0.01] and  CORT [F(1,8) = 9.201, p < 0.01]. Detailed post-hoc tests revealed that 
both ACTH (Fig. 2B) and CORT (Fig. 2D) in either wt or dtg mice reached the peak level at 1 
hr after the AS, while a significant difference was observed at 1 and 2 hr in ACTH between 
wt and dtg groups (p > 0.05), and at 1 and 2 hr in CORT between wt and dtg groups (p > 
0.05). In both wt and dtg mice, ACTH returned to the basal level at 4 hr (Fig. 2B), while 
CORT returned to the basal level at 4 hr (Fig. 2D). All these results indicate that the 
interaction between the AT and CCKR-2 transgene does not only increase the activity of the 
HPA axis following a novel stressor, but also impairs the CORT negative feedback in 
response this stressor.  
3.3. Disassociation of the CCKR2 transgene expression and AT largely 
diminishes the effect of AT on HPA axis activity in response to AS  
In this study, both wt and dtg mice were treated with doxycycline (doxy, 2 mg/100 ml in 
drinking water) for 5 days prior to AT, so that the transgene expression in dtg mice was 
inhibited during the episode of AT, and this inhibition lasted for about 3-5 days after the 
doxy treatment. At 2 months old, these mice were subjected to AS, and 1 hr later, which is 
the peak time of HPA axis response, as described in Fig. 2, the HPA axis activity was 
measured. Surprisedly, the levels of both ACTH and CORT were indistinguishable between 
wt and dtg mice, indicating that the coupling of AT and the transgene expression is critical 
for the AT to produce impaired glucocorticoid negative feedback inhibition in the animals.  
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Figure 2. Increased HPA axis activity in dtg mice with AT/AS. A. Basal serum level of ACTH in naïve 
wt mice and naïve dtg mice. A tendency of a difference is shown, but it is not significant. Data are 
expressed as mean ± SEM. B. Time-course of ACTH response following the AS. C. Basal serum level of 
CORT in naïve wt mice and naïve dtg mice. A tendency of a difference is shown, but it is not significant. 
Data are expressed as mean ± SEM. D. Time-course of CORT response following the AS. The same 
groups of mice above were examined.  
 
Figure 3. Level of ACTH (A) and CORT (B) in the mice after AT/AS. No significant difference was 
found between wt and dtg mice when the expression of the CCKR-2 transgene was suppressed during 
AT. 
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4. Discussion  
We have for the first time demonstrated that a coupling of a higher CCKergic tone with an 
ELS event is a causative factor for the development of an impairment of glucocorticoid 
negative feedback inhibition in the animals in response to additional acute stressor at a later 
life stage.  
This demonstration is achieved based on the technical merit in our transgenic mice, in which 
the transgene expression is inducible/reversible. The time resolution for this 
inducible/reversible feature is within 1 week, which is high enough for this time-coupling 
analysis. However, it is still not clear how this real-time coupling occurs, partially due to the 
fact that the functional significance of the CCKergic system is still not fully understood. As 
G protein-coupled receptors, CCKR are associated with Ca2+ release, PKC activation, PLA2 
activity, and cAMP production [120]. In addition, there are robust interactions between the 
CCKergic system and other neurotransmitter systems including dopaminergic, serotonergic, 
and GABAergic systems at both the structural and functional levels [121,122], and therefore, 
the mechanism underlying this associative effect should be complicated, and need to be 
further studied.  
An important finding in this study is the discovery of the change in the HPA axis activity, 
and these changes include (1) a slightly lower basal level of the HPA axis activity in dtg 
mice, compared to wt mice, (2) a synergistic effect of AT and the CCKR-2 transgene on the 
peak level of the HPA axis activity in response to the AS; (3) a prolonged decay time of the 
HPA axis activity following the AS in dtg mice with AT, and (4) a requirement of real-time 
coupling of the transgene expression and TA. It should be mentioned that it has been well 
established that a previous chronic stress in the animals down-regulates the HPA axis 
activity, but enhances their response to a novel acute stress, despite the negative feedback 
effects [83,123,124]. Because chronic stress can specifically facilitate the release of CCK into 
the PVN, which directly projects to the pituitary, in response to acute stress [88], the elevated 
CCKergic tone in our dtg mice may mimic the effect of a chronic stress by working as an 
“intrinsic stressor” for the animals. Therefore, this intrinsic stressor constitutes a basis for the 
higher vulnerability of dtg mice to AT. At the same time, the impaired AS-induced CORT 
negative feedback response may, in tern, significantly alter many other physiological 
functions, and eventually lead to a pathological condition. 
As described above, following ELS, neuroanatomical changes were found in different brain 
regions. In addition, neuronal activity is altered too {125}. Consistent to the current study, 
the activity of the HPA axis system in the subject who experienced ELS was dysregulated 
[48-52]. Moreover, many other neurotransmitter systems were also affected by ELS [40, 126-
128]. Therefore, the finding from the current study has provided additional evidence 
regarding how the CCKergic system and the HPA axis system are involved in the 
pathogenesis of post-ELS disorders. 
The most important finding in this study is the demonstration of that if the transgene was 
temporally suppressed during the time of AT exposure, this impaired HPA axis inhibition 
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in response to another acute stressor was largely diminished, indicating that the temporal 
association of the elevated CCKergic tone with AT is critically pathogenic.  This finding has 
a potential translational significance. It is well know that the endogenous CCKergic activity, 
or the CCKR-2 level in the brain, plays a dominant role in the expression of anxiety. For 
example, the expression of anxiety was correlated with the increased CCKergic tone, which 
was evidenced by a higher CCK receptor-binding capacity in the brain of anxious animals, 
in comparison with non-anxious animals [129-131]. Different fear responses among different 
strains of the same animal species were attributed to different expression levels of CCKR-2 
[132-134]. On the other hand, evidence also indicates that the CCKergic tone in the brain is 
dynamically regulated by stress. Following stress, for example, both CCK peptide 
immunoreactivity and CCK receptor density in the brain were significantly increased [135-
139]. Social isolation, an anxiogenic stress, increased the CCK mRNA expression in the 
brain [140]. Especially, the effect of ELS on the HPA axis activity was associated with CCK 
activity [87]. Chronic stress could specifically facilitate the release of CCK into the PNV in 
response to acute stress [84,141]. Consistently, CCKR-2 agonists could only produce, or 
produce more pronounced, anxiogenic effect in stressed animals, but not in un-stressed 
animals [88, 142-144]. Patients with ADs were more sensitive to CCKR-2 agonists than 
normal controls [145-148]. Together with all these findings, it seems conclusive that the 
CCKergic system is dynamically involved in ELS-triggered mental disorders, and thus, an 
inhibition of the CCKergic tone timely associated with an ELS event might be useful to 
prevent the development of post-ELS disorder, especially ADs. 
In summary, our study has revealed a Novel molecular underpinning for the development 
of post-ESL disorders, especially for mental disorders, and provide insightful information 
regarding how can we develop a preventive strategy for these post-ESL disorders in the 
humans.  
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